SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, a foreign private issuer, reports a transaction in the company's own shares. The report covers the month of April 2025, specifically detailing share repurchases executed on April 7, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share buybacks executed under an existing non-discretionary agreement with Citigroup Global Markets Limited.
- Date of Purchase: April 7, 2025
- Shares Purchased (Daily): 1,454,000 ordinary shares
- Price Range (GBp): 1,324.50p (Low) to 1,376.50p (High)
- Volume-Weighted Average Price (GBp): 1,347.28p
- Trading Venue: London Stock Exchange (XLON)
- Program Status: Since the agreement commenced on February 24, 2025, the Company has purchased a total of 22,687,637 ordinary shares.
Capital Structure and Treasury Holdings
Following the April 7 transaction, the Company's share capital structure is as follows:
- Treasury Shares Held: 191,757,940 ordinary shares
- Ordinary Shares in Issue (excluding Treasury): 4,123,469,142
- Total Voting Rights: 4,123,469,142
The purchased shares are held as Treasury shares. The filing notes that the total voting rights figure should be used by shareholders as the denominator for calculating notification thresholds under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Material Changes and Outlook
This filing represents a routine update on the execution of the Company's share buyback program. There are no material changes to the Company's financial position, revenue, or profit reported in this specific document, as it is a transactional disclosure rather than a financial results report. The buyback program continues pursuant to the agreement announced on February 24, 2025.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback program since February 24, 2025 (22,687,637).
- Confirm the current number of Treasury shares held (191,757,940) against previous filings to track program progress.
- Review the volume-weighted average price (1,347.28p) to assess the cost basis of the repurchased shares relative to market conditions.
- Check the total voting rights (4,123,469,142) for accurate calculation of beneficial ownership thresholds.